Evidence for degradation of heparan sulfate by endoglycosidases: glucosamine and hexuronic acid are reducing terminals of intracellular heparan sulfate from human skin fibroblasts.
D000818:Animals; D001011:Aorta; D002417:Cattle; D002478:Cells, Cultured; D005347:Fibroblasts / Q000201:enzymology; D005944:Glucosamine / Q000032:analysis; D006025:Glycosaminoglycans / Q000378:metabolism*; D006026:Glycoside Hydrolases / Q000378:metabolism*; D006497:Heparan Sulfate / Q000378:metabolism*; D006801:Humans; D008059:Mucopolysaccharidosis I / Q000378:metabolism; D009084:Mucopolysaccharidosis III / Q000378:metabolism; D009844:Oligosaccharides / Q000032:analysis; D012867:Skin / Q000201:enzymology*; D014574:Uronic Acids / Q000032:analysis
D005944:Glucosamine; D006025:Glycosaminoglycans; D006026:Glycoside Hydrolases; D006497:Heparan Sulfate; D009844:Oligosaccharides; D014574:Uronic Acids